-
Mashup Score: 4
In this short documentary video from the _New England Journal of Medicine_ (NEJM), patients and physicians partner both to highlight the experience of living…
Source: YouTubeCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 2
Original Article from The New England Journal of Medicine — Rivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation
Source: New England Journal of MedicineCategories: Hem/Oncs, Latest HeadlinesTweet-
.#NEJM: Among patients with #rheumatic #HeartDisease-associated atrial #fibrillation, vitamin K antagonist therapy led to a lower rate of a composite of #cardiovascular events or death than #rivaroxaban therapy, without a higher rate of bleeding. #INVICTUS https://t.co/xpxplocoSG https://t.co/PQGUMiK5RE
-
-
Mashup Score: 0
Original Article from The New England Journal of Medicine — Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge
Source: New England Journal of MedicineCategories: Hem/Oncs, Latest HeadlinesTweet-
.#NEJM: Among patients aged 65 yrs or older, rates of #hospitalization & death due to #Covid19 were significantly lower in those receiving #nirmatrelvir than in those who did not. No #evidence of #outcome benefit found in younger adults. #Paxlovid @NIHCEAL https://t.co/uVyhazDUHv https://t.co/K6lRBtjsyj
-
-
Mashup Score: 0Tobacco Addiction | NEJM - 2 year(s) ago
Clinical Practice from The New England Journal of Medicine — Tobacco Addiction
Source: New England Journal of MedicineCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Effectiveness of BNT162b2 Vaccine against Omicron in Children 5 to 11 Years of Age | NEJM - 2 year(s) ago
Original Article from The New England Journal of Medicine — Effectiveness of BNT162b2 Vaccine against Omicron in Children 5 to 11 Years of Age
Source: New England Journal of MedicineCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 0
Editorial from The New England Journal of Medicine — Lawmakers v. The Scientific Realities of Human Reproduction
Source: New England Journal of MedicineCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Pivotal olaparib/abiraterone mCRPC data published in New England Journal of Medicine Evidence - 2 year(s) ago
The phase 3 PROpel trial showed that adding the PARP inhibitor olaparib to frontline abiraterone acetate significantly improved radiographic progression-free survival in patients with metastatic castration-resistant prostate cancer.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0Nineteen Days in America | NEJM - 2 year(s) ago
Perspective from The New England Journal of Medicine — Nineteen Days in America
Source: New England Journal of MedicineCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
Tratamento medicamentoso inédito tem tudo para melhorar a vida dos portadores dessa doença rara
Source: Veja SaúdeCategories: Hematologists1, Latest HeadlinesTweet
-
Mashup Score: 0
Editorial from The New England Journal of Medicine — A New Standard Immunosuppression Regimen in Severe Aplastic Anemia
Source: New England Journal of MedicineCategories: Hematologists1, Latest HeadlinesTweet
Rooted in the patient experience of life with #SickleCellDisease, this short documentary breaks down the pathophysiology and new treatments for sickle cell disease, including gene therapy. Watch at https://t.co/Dj40W3dtUP. #NEJM #SickleCellAwarenessMonth #SickleCellAnemia https://t.co/rSpmQiQqNk